Along with the pharmaceutical industry, the bio-tech industry contributes a significant percentage of the national GDP. This industry is a thriving industry, which accounts for much of the bio-tech operations in the whole of Europe. The UK bio-tech industry is one that is characterized by constant innovation and capital investment opportunities. Quanta is able to provide a specialized recruiting service to this industrial sector. Like all other sectors the economy, the introduction of new government recruitment regulations will always affect the way the industry selects suitable candidates. It is worth mentioning that one of the major challenges which the bio-tech industry is currently facing is rising costs. New government recruitment regulations have the potential to increase these costs. Clinical trials is crucial for the bio-tech industry.
This activity requires a substantial investment in time and capital. For sure, all bio-tech companies must adhere to government regulations on recruiting subjects for these trials. They must also meet all health and safety guidelines, which govern the conduct of these trials. If a bio-tech company fails to comply with all recruitment regulations, they could potentially face legal action and fines. In terms of recruiting staff to work on bio-tech company sites, there is a new regulation that could affect how bio-tech companies conduct their operations. The new regulation on age discrimination means that bio-tech companies can no longer take age into consideration when making recruitment decisions. All bio-tech companies must ensure that job applicants and employees are not discriminated against on the grounds of their age. Each company is responsible for ensuring that their staff also fully comply with this regulation.
The regulation inevitably means that bio-tech companies will have invest money in training and educating staff on the regulation. Doing this may exacerbate the problem of rising costs, which the industry is currently facing. The consequence that could result from this includes the fact that an increasing number of bio-tech companies may start outsourcing their employment overseas. This scenario could lead to an increase in redundancies and unemployment in this sector. At the very least, the new regulation could lead to bio-tech employers setting more stringent employment requirements and qualifications. Should this happen, lower qualified individuals may find it increasingly difficult to secure a suitable job. In any case, Quanta looks to ensure that both our bio-tech candidates and clients obtain the best recruitment service possible.